ECHQF (Echo IQ) Risk Assessment


ECHQF Echo IQ Ltd ECHQF
13 GF Score
Price $1.25
GF Value $0.02
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Echo IQ Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Echo IQ is: No Data: Cannot be evaluated.

Echo IQ  (OTCPK:ECHQF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Echo IQ Risk Assessment Related Terms

ECHQF vs VEEV, BTSG, TEM: Risk Assessment Comparison

For the Health Information Services subindustry, Echo IQ's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Echo IQ Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Echo IQ's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Echo IQ's Risk Assessment falls into.


ECHQF
13GF Score
Echo IQ Ltd ECHQF
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Echo IQ (ECHQF) Overvalued in 2026?

Based on GuruFocus' analysis, Echo IQ stock appears to be overvalued. The current stock price of $1.25 is trading 6150% above its estimated GF Value™ of $0.02. GuruFocus considers Echo IQ to be Significantly Overvalued.

Key valuation signals for ECHQF:

  • Risk Assessment:
  • GF Value™: $0.02 vs. price of $1.25 (6150% above fair value)
  • GF Score™: 13/100 with 2 warning signs

No single metric tells the full story. See the ECHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Echo IQ Business Description

Other Exchanges PL4:GermanyEIQ:Australia
Address 264 Stirling Highway, U5, Claremont, Perth, WA, AUS, 6010
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
13GF Score

Get the complete analysis for ECHQF

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25
Price
$0.02
GF Value